<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Uveitis: Etiology, clinical manifestations, and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Uveitis: Etiology, clinical manifestations, and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Uveitis: Etiology, clinical manifestations, and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            George N Papaliodis, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jennifer E Thorne, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Siobhan M Case, MD, MHS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 27, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Uveitis, the process of intraocular inflammation, may result from many causes. Referral to an ophthalmology specialist is indicated for the diagnosis and management of most patients with symptoms suggesting uveal tract inflammation.
        </p>
        <p>
         The definition of uveitis and its subsets; causes of uveitis and differential diagnosis of underlying conditions; clinical manifestations, diagnosis, and differential diagnosis of uveitis; and the role of the non-ophthalmologist in the diagnostic evaluation of patients with uveitis are described here. The treatment of uveitis is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/5592.html" rel="external">
          "Uveitis: Treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          DEFINITIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Uveitis is characterized by inflammation of the uvea, which is the middle portion of the eye; the anterior portion of the uvea includes the iris and ciliary body, and the posterior portion of the uvea is known as the choroid  (
         <a class="graphic graphic_figure graphicRef57690" href="/z/d/graphic/57690.html" rel="external">
          figure 1
         </a>
         ). The term "uvea" derives from the Latin word for "grape," since anatomists once thought that the peeling of the outside of the eye left a grape-like structure beneath.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inflammation of the anterior uveal tract, characterized by the presence of leukocytes in the anterior chamber of the eye, is called anterior uveitis and is synonymous with iritis. When the adjacent ciliary body is also inflamed, the process is known as iridocyclitis [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The presence of leukocytes in the vitreous humor and evidence of active chorioretinal inflammation are diagnostic of intermediate uveitis and posterior uveitis, respectively. Terms used to describe forms of uveitis posterior to the lens include vitritis, intermediate uveitis, pars planitis, choroiditis, retinitis, chorioretinitis, and retinochoroiditis [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Panuveitis is defined as simultaneous inflammation in the anterior chamber, vitreous humor, and retina or choroid.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          ETIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Uveitis frequently occurs in association with other systemic medical conditions, especially infections and inflammatory diseases, but may occur as an isolated process. Individual forms of uveitis may be distinguished on the basis of location within the eye (see
         <a class="local">
          'Definitions'
         </a>
         above); onset, symmetry and continuity of inflammation; associated complications (see
         <a class="local">
          'Complications'
         </a>
         below); and distribution of cells along the corneal endothelium. The latter changes are known as keratic precipitates  (
         <a class="graphic graphic_picture graphicRef71161" href="/z/d/graphic/71161.html" rel="external">
          picture 1
         </a>
         ). Both the size and distribution of keratic precipitates are helpful in the differential diagnosis of the underlying cause. The diversity of keratic precipitates is especially appreciated by magnified images obtained with confocal microscopy [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Uveitis may be divided into four major subsets based upon the etiology of the inflammation  (
         <a class="graphic graphic_table graphicRef61247 graphicRef75844 graphicRef55902" href="/z/d/graphic/61247.html" rel="external">
          table 1A-C
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infections (see
         <a class="local">
          'Infectious causes'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Systemic immune-mediated disease, including:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Systemic inflammatory diseases (see
         <a class="local">
          'Systemic inflammatory diseases'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other immune-related conditions (see
         <a class="local">
          'Drugs and hypersensitivity reactions'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Syndromes usually confined to the eye (see
         <a class="local">
          'Uveitis syndromes usually restricted to the eye'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Masquerade syndromes such as lymphoma, leukemia, or retinal degeneration that result in a leukocyte response that can easily be mistaken for inflammation  (
         <a class="graphic graphic_table graphicRef64117" href="/z/d/graphic/64117.html" rel="external">
          table 2
         </a>
         ) (see
         <a class="local">
          'Differential diagnosis'
         </a>
         below)
        </p>
        <p>
        </p>
        <p>
         Approximately 40 percent of patients have uveitis associated with a systemic immune-mediated disease in the author's referral population; the proportion of patients with each type of uveitis in an unselected general population is uncertain and varies between populations. Approximately 30 percent of patients with uveitis do not fit into any well-defined diagnostic category and are usually labeled as having idiopathic uveitis. Other alternative terms for idiopathic uveitis include undifferentiated and unclassifiable uveitis.
        </p>
        <p>
         A genetic predisposition may contribute to the development of uveitis. For example, birdshot chorioretinitis is strongly associated with human leukocyte antigen (HLA)-A29, and acute anterior uveitis is associated with HLA-B27 Epidemiologic data have also shown differences in incidence among different ethnicities, further supporting a role for genetic factors [
         <a href="#rid3">
          3
         </a>
         ]. A few studies have also suggested that cigarette smoking may be associated with an increased risk of uveitis and with increased severity [
         <a href="#rid4">
          4,5
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Infectious causes
         </span>
         <span class="headingEndMark">
          —
         </span>
         The infectious causes of uveitis include bacterial and spirochetal diseases, viral diseases, fungal infections, and parasitic infections  (
         <a class="graphic graphic_table graphicRef61247" href="/z/d/graphic/61247.html" rel="external">
          table 1A
         </a>
         ). These infections generally have distinctive presentations and are likely to affect different populations. In addition, broad-spectrum amplification of pathogen ribonucleic acid (RNA) or deoxyribonucleic acid (DNA) using ocular fluid has implicated an infectious cause of uveitis in nearly 10 percent of patients for whom no other cause was found [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Herpes virus
         </strong>
         – Both herpes simplex and herpes zoster can cause a keratouveitis, which is usually unilateral. Keratouveitis is an inflammation of the cornea along with uveitis that is primarily anterior. The presence of cutaneous vesicles, characteristic corneal changes, reduced corneal sensation, elevated intraocular pressure, and iris atrophy may be clues to the diagnosis. Both herpes simplex and zoster can also cause a retinitis known as acute retinal necrosis. This is a rare but treatable cause of visual loss. (See
         <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Ocular manifestations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8327.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes zoster", section on 'Herpes zoster ophthalmicus'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cytomegalovirus
         </strong>
         – Cytomegalovirus (CMV) as a cause for posterior uveitis in adults is found almost exclusively in the immunocompromised host, especially patients with human immunodeficiency virus (HIV) infection and extremely low CD4 counts  (
         <a class="graphic graphic_picture graphicRef60120" href="/z/d/graphic/60120.html" rel="external">
          picture 2
         </a>
         ). Uveitis (CMV retinitis) is the most common serious ocular complication of the acquired immunodeficiency syndrome (AIDS) and is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3746.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of AIDS-related cytomegalovirus retinitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         CMV infection is also an uncommon cause of anterior uveitis in patients in North America or Europe. It is much more common in southeast Asia, where it occurs in patients who are not immunocompromised and who often present with ocular hypertension [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8289.html" rel="external">
          "Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent adults", section on 'Ocular manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Toxoplasmosis
         </strong>
         – Toxoplasmosis is a surprisingly common cause of uveitis in the normal host. In many instances, it is presumed to be a reactivation of a congenitally acquired infection. It is suspected on the basis of a typical chorioretinal lesion  (
         <a class="graphic graphic_picture graphicRef69853" href="/z/d/graphic/69853.html" rel="external">
          picture 3
         </a>
         ); the diagnosis is supported by serology. Serologic evidence for previous infection by toxoplasmosis is extremely common in the healthy United States population [
         <a href="#rid8">
          8
         </a>
         ]. Most chorioretinal scarring from toxoplasmosis is due to infection during gestation, but scarring is increasingly recognized as a result of recent infection [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3710.html" rel="external">
          "Toxoplasmosis in patients with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5699.html" rel="external">
          "Toxoplasmosis: Ocular disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Ocular toxoplasmosis can affect both normal and immunocompromised hosts but is far more common in immunocompetent patients, in contrast to central nervous system toxoplasmosis, which is seen almost exclusively in the immune-compromised.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Syphilis
         </strong>
         – Syphilis accounts for less than 1 percent of patients with uveitis in most large series. It may present in a variety of forms, including posterior uveitis, such as a chorioretinitis or retinal vasculitis  (
         <a class="graphic graphic_picture graphicRef59760" href="/z/d/graphic/59760.html" rel="external">
          picture 4
         </a>
         ) [
         <a href="#rid10">
          10
         </a>
         ]. It is critical to recognize syphilis because of its important therapeutic implications. (See
         <a class="medical medical_review" href="/z/d/html/7599.html" rel="external">
          "Neurosyphilis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tuberculosis
         </strong>
         – Tuberculosis is an uncommon cause of uveitis in North American referral centers. It should be considered in the differential diagnosis when the uveitis worsens despite glucocorticoid therapy. Additional factors that raise suspicion for this diagnosis are active tuberculosis elsewhere in the body, cachexia, homelessness, a history of incarceration, a granulomatous appearance for the ocular inflammation, or immunosuppression. In some geographic areas such as Saudi Arabia, tuberculosis is considered a common cause of uveitis. (See
         <a class="medical medical_review" href="/z/d/html/7999.html" rel="external">
          "Tuberculosis and the eye"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cat-scratch disease
         </strong>
         – Cat scratch disease is increasingly recognized as a cause of uveitis that is typically unilateral. Although the uveitis associated with cat scratch disease can have a variable presentation, a macular star and optic nerve edema are especially characteristic  (
         <a class="graphic graphic_picture graphicRef69294" href="/z/d/graphic/69294.html" rel="external">
          picture 5
         </a>
         ) [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5532.html" rel="external">
          "Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          West Nile virus
         </strong>
         – West Nile viral infection can cause chorioretinitis in association with a retinal vasculitis. Uveitis is a common feature of this viral disease and may be asymptomatic. (See
         <a class="medical medical_review" href="/z/d/html/1273.html" rel="external">
          "Clinical manifestations and diagnosis of West Nile virus infection", section on 'Ocular manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ebola virus disease
         </strong>
         – The occurrence of uveitis during the convalescent phase of Ebola virus disease has been reported in four patients in one case series [
         <a href="#rid12">
          12
         </a>
         ], as well as another patient in a separate case report in which viable virus was obtained from the aqueous humor of the affected eye nine weeks after clearance of viremia [
         <a href="#rid13">
          13
         </a>
         ]. In a study of 277 survivors of Ebola in Sierra Leone, 60 percent had new ocular symptoms and 18 percent were diagnosed with uveitis [
         <a href="#rid14">
          14
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3022.html" rel="external">
          "Clinical manifestations and diagnosis of Ebola virus disease", section on 'Signs and symptoms'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3022.html" rel="external">
          "Clinical manifestations and diagnosis of Ebola virus disease", section on 'Convalescence'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3023.html" rel="external">
          "Epidemiology and pathogenesis of Ebola virus disease", section on 'Risk of transmission through different body fluids'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Zika virus disease
         </strong>
         – The Zika virus appears to be another infectious cause of uveitis, including both presumed congenital disease and uveitis in adults with active infection. In 2015, during an epidemic outbreak of this infection, 29 infants with microcephaly underwent detailed eye examinations at a tertiary center in Brazil [
         <a href="#rid15">
          15
         </a>
         ]. Twenty-three of the 29 mothers had symptoms consistent with Zika exposure during pregnancy. Ten of the 29 infants had ocular abnormalities such as chorioretinal atrophy, pigmentary mottling of the retina, or optic nerve disease. These findings are consistent with Zika exposure in utero resulting in scarring of the uveal tract. Both anterior and posterior uveitis have also been reported as a component of active infection with Zika in case reports [
         <a href="#rid16">
          16,17
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/106169.html" rel="external">
          "Zika virus infection: An overview"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          COVID-19 infection or vaccination
         </strong>
         <strong>
          –
         </strong>
         A variety of retinal and/or choroidal inflammations including microvascular disease have been rarely reported in the setting of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (coronavirus disease 2019 [COVID-19]) [
         <a href="#rid18">
          18,19
         </a>
         ]. Similarly, vaccination against COVID-19 has been reported to be a rare cause of uveitis or a trigger to exacerbate uveitis [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fuchs heterochromic iridocyclitis
         </strong>
         – Fuchs heterochromic iridocyclitis, a form of chronic unilateral, primarily anterior uveitis, is now considered to be most often secondary to a remote infection with rubella [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H56536032">
         <span class="h2">
          Systemic immune-mediated causes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Uveitis can occur as a manifestation of many systemic inflammatory conditions, including the spondyloarthritis (SpA) family of disorders, sarcoidosis, other systemic rheumatic diseases, and other systemic disorders  (
         <a class="graphic graphic_table graphicRef55902" href="/z/d/graphic/55902.html" rel="external">
          table 1C
         </a>
         ). Uveitis is only rarely due to a reaction to a medication.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Systemic inflammatory diseases
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Spondyloarthritis
         </strong>
         – Spondyloarthritides, such as ankylosing spondylitis and reactive arthritis, are the most common systemic immune disorders associated with uveitis in North America and Europe [
         <a href="#rid22">
          22
         </a>
         ]. Twenty to 40 percent of patients with either of these HLA-B27-related disorders develop the sudden onset of anterior uveitis. When it occurs, uveitis is often the manifestation to suggest the diagnosis of the systemic illness. As an example, one study found that 40 percent of patients presenting to an ophthalmology emergency department for acute anterior uveitis without a prior diagnosis had a form of SpA as the underlying cause [
         <a href="#rid23">
          23
         </a>
         ]. Uveitis in association with SpA is approximately twice as common in males as in females.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Uveitis in association with SpA is typically unilateral and tends to resolve within three months of its onset. Recurrences are common and can occur in the contralateral eye. The prognosis for this form of uveitis is generally excellent. (See
         <a class="medical medical_review" href="/z/d/html/7795.html" rel="external">
          "Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">
          "Reactive arthritis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients with recurrent anterior uveitis without back or joint symptoms or the diagnosis of SpA, particularly those who are HLA-B27-positive, may have an incomplete form of SpA. A strong association was seen between patients with recurrent acute anterior uveitis and the presence of inflammation at the tendon or ligament insertion (enthesitis) demonstrated by ultrasound, despite the absence of clinical symptoms of spondyloarthropathy [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sarcoidosis
         </strong>
         – Sarcoidosis accounts for a significant percentage of patients with uveitis in most series from referral centers [
         <a href="#rid25">
          25-27
         </a>
         ]. Approximately 20 percent of patients develop eye disease as their initial presentation of sarcoid. The eye disease can take on many forms, including uveitis, dry eyes, optic neuritis, lid inflammation, or orbital disease [
         <a href="#rid28">
          28
         </a>
         ]. Uveitis in patients with sarcoid is frequently associated with retinal vasculitis, which may be either perivascular or involve retinal vascular changes  (
         <a class="graphic graphic_picture graphicRef77545" href="/z/d/graphic/77545.html" rel="external">
          picture 6
         </a>
         ) [
         <a href="#rid29">
          29
         </a>
         ]. The eye disease may persist despite the resolution of adenopathy [
         <a href="#rid30">
          30
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4353.html" rel="external">
          "Clinical manifestations and diagnosis of sarcoidosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Juvenile idiopathic arthritis
         </strong>
         – Juvenile idiopathic arthritis (JIA) may be associated with uveitis, particularly in the subset of patients with oligoarticular disease and a positive antinuclear antibody. The onset of uveitis is usually between the ages of two and eight and is asymptomatic in the majority of patients.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The uveitis associated with JIA is usually bilateral, insidious in onset, chronic in duration, and anterior. The eye disease is commonly associated with complications such as band keratopathy, posterior synechiae  (
         <a class="graphic graphic_picture graphicRef52468" href="/z/d/graphic/52468.html" rel="external">
          picture 7
         </a>
         ), cataract formation, and glaucoma. The uveitis sometimes lasts for decades, long after the joint disease has disappeared. Uveitis in children with oligoarticular disease and recommendations for screening are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/6415.html" rel="external">
          "Oligoarticular juvenile idiopathic arthritis", section on 'Uveitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Psoriatic arthritis and inflammatory bowel disease
         </strong>
         – Seven percent of patients with psoriatic arthritis and 2 to 9 percent of patients with inflammatory bowel disease (IBD, Crohn's disease, or ulcerative colitis) may develop uveitis [
         <a href="#rid31">
          31,32
         </a>
         ]. The uveitis is associated with HLA-B27 in approximately 45 percent of cases with IBD. (See
         <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">
          "Clinical manifestations and diagnosis of psoriatic arthritis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4070.html" rel="external">
          "Clinical manifestations, diagnosis, and prognosis of Crohn disease in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4067.html" rel="external">
          "Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Both psoriatic arthritis and the arthritis associated with IBD are considered forms of SpA; however, in contrast to the uveitis associated with ankylosing spondylitis and reactive arthritis, uveitis associated with IBD or psoriatic arthritis is frequently bilateral, posterior to the lens, insidious in onset, chronic in duration, and more common in females than males [
         <a href="#rid32">
          32,33
         </a>
         ]. Approximately 75 percent of patients with uveitis and IBD have an associated arthritis that may be axial and/or peripheral. In 10 of 17 patients in one series, the uveitis preceded signs of IBD [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tubulointerstitial nephritis and uveitis syndrome
         </strong>
         – Tubulointerstitial nephritis and uveitis (TINU) syndrome is an uncommon disorder that occurs most often in adolescents and young women, who may also exhibit additional systemic symptoms and findings including fever, myalgias, mild anemia, and abnormal liver function tests. Patients may experience bilateral, recurrent, or chronic uveitis. Because interstitial nephritis and uveitis can also occur together in sarcoidosis and in Sjögren's disease, patients with TINU syndrome should be evaluated for these disorders as well. The TINU syndrome is discussed in more detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/7189.html" rel="external">
          "Tubulointerstitial nephritis and uveitis (TINU syndrome)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Multiple sclerosis
         </strong>
         – Multiple sclerosis (MS) is most commonly associated with optic neuritis, but may also cause a granulomatous anterior uveitis or pars planitis. Females with pars planitis in association with a periretinal vascular infiltrate, known as periphlebitis  (
         <a class="graphic graphic_picture graphicRef60574" href="/z/d/graphic/60574.html" rel="external">
          picture 8
         </a>
         ), have about a 30 percent risk of developing MS [
         <a href="#rid34">
          34,35
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1689.html" rel="external">
          "Manifestations of multiple sclerosis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vogt-Koyanagi-Harada syndrome
         </strong>
         – Vogt-Koyanagi-Harada syndrome (VKH) is the second leading cause of uveitis in Japan after Behçet syndrome [
         <a href="#rid36">
          36
         </a>
         ]. VKH is presumably an autoimmune disease that is manifested by bilateral posterior uveitis with characteristic fluid accumulation beneath the retina, leading to retinal elevation and detachment [
         <a href="#rid37">
          37,38
         </a>
         ]. It often presents as a panuveitis. The diagnosis of VKH is based upon the clinical presentation; there are no serologic tests or specific histological changes. Patients with VKH may also develop vitiligo, poliosis (loss of color from a patch of hair), sterile meningitis, alopecia, and eighth cranial nerve disease. The disease is common among Hispanic populations in addition to southeast Asian populations. VKH has a strong HLA class II association (specifically with the HLA-D locus and DR4 allele) [
         <a href="#rid39">
          39
         </a>
         ]. Similar retinal elevation may occur in central serous chorioretinopathy, a rare disorder that has been associated with glucocorticoid use (see
         <a class="medical medical_review" href="/z/d/html/7988.html" rel="external">
          "Major adverse effects of systemic glucocorticoids", section on 'Ophthalmologic effects'
         </a>
         ). Scleritis affecting the posterior sclera is also a potential cause of multiple serous elevations of the retina.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Behçet syndrome
         </strong>
         – As many as 80 percent of patients with Behçet syndrome develop uveitis [
         <a href="#rid40">
          40
         </a>
         ]. Uveitis is often the dominant manifestation of this disease and is typically bilateral. Similar to HLA-B27-associated iritis, it is frequently episodic; but, unlike HLA-B27-associated disease, the uveitis generally does not resolve completely between episodes. Behçet uveitis often presents as a panuveitis, and retinal vasculitis is a frequent manifestation of Behçet syndrome  (
         <a class="graphic graphic_picture graphicRef64705" href="/z/d/graphic/64705.html" rel="external">
          picture 9
         </a>
         ). The uveitis typically leads to blindness if the eye inflammation is not treated [
         <a href="#rid41">
          41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8223.html" rel="external">
          "Clinical manifestations and diagnosis of Behçet syndrome", section on 'Ocular disease'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Kawasaki disease
         </strong>
         – Kawasaki disease may be associated with a mild anterior uveitis, which may be accompanied by conjunctivitis. (See
         <a class="medical medical_review" href="/z/d/html/6417.html" rel="external">
          "Kawasaki disease: Clinical features and diagnosis", section on 'Conjunctivitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Relapsing polychondritis
         </strong>
         – A high percentage of patients with relapsing polychondritis also have ocular involvement. The eye disease occurs in many forms, including episcleritis, scleritis, and uveitis. Ocular involvement in relapsing polychondritis is discussed in more detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5606.html" rel="external">
          "Clinical manifestations of relapsing polychondritis", section on 'Eye involvement'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sjögren's disease
         </strong>
         – In Sjögren's disease, a very small percentage of patients develop chronic anterior and posterior uveitis, and it is possible that uveitis causes secondary ocular dryness [
         <a href="#rid42">
          42
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5607.html" rel="external">
          "Clinical manifestations of Sjögren's disease: Exocrine gland disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Systemic lupus erythematosus
         </strong>
         – Systemic lupus erythematosus (SLE) can involve the eye in a variety of forms [
         <a href="#rid43">
          43
         </a>
         ]. Dryness is the most common ocular manifestation; cotton wool spots  (
         <a class="graphic graphic_picture graphicRef67621" href="/z/d/graphic/67621.html" rel="external">
          picture 10
         </a>
         ) occur in about 7 percent of patients and indicate local retinal ischemia [
         <a href="#rid44">
          44
         </a>
         ]. Anterior uveitis is a rare manifestation. (See
         <a class="medical medical_review" href="/z/d/html/4668.html" rel="external">
          "Clinical manifestations and diagnosis of systemic lupus erythematosus in adults", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Systemic vasculitis
         </strong>
         – Except for Behçet syndrome, uveitis is infrequently associated with other systemic vasculitides, including polyarteritis and granulomatosis with polyangiitis [
         <a href="#rid45">
          45
         </a>
         ]. More typical vision-threatening manifestations of granulomatosis with polyangiitis are scleritis and orbital disease. The term retinal vasculitis often causes confusion. In part, this results from diagnosing retinal vasculitis on the basis of vascular leakage as seen by a
         <a class="drug drug_general" data-topicid="8461" href="/z/d/drug information/8461.html" rel="external">
          fluorescein
         </a>
         angiogram or on the basis of perivascular infiltrate as seen on examination. Similar criteria are not used to diagnose systemic vasculitis. Retinal vasculitis can be secondary to a disease such as sarcoidosis or birdshot chorioretinopathy, which are not generally categorized as vasculitides. (See
         <a class="medical medical_review" href="/z/d/html/8245.html" rel="external">
          "Clinical manifestations and diagnosis of polyarteritis nodosa in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3117.html" rel="external">
          "Granulomatosis with polyangiitis and microscopic polyangiitis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Primary angiitis of the central nervous system
         </strong>
         – Granulomatous angiitis of the central nervous system may also be accompanied by inflammation of the uvea [
         <a href="#rid46">
          46
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8230.html" rel="external">
          "Primary angiitis of the central nervous system in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Blau syndrome
         </strong>
         – One of the rarest forms of uveitis is Blau syndrome. This disease, transmitted in an autosomal dominant pattern, is characterized by the development of noncaseating granulomatous inflammation of the uvea, skin, and joints. (See
         <a class="medical medical_review" href="/z/d/html/5597.html" rel="external">
          "The autoinflammatory diseases: An overview"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The Standardization of Uveitis Nomenclature (SUN) working group has relied on machine learning to develop classification criteria for multiple forms of uveitis [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H56535411">
         <span class="h3">
          Drugs and hypersensitivity reactions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Drug or hypersensitivity reactions are a rare cause of uveitis. The following drugs are among those that have been implicated:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9863" href="/z/d/drug information/9863.html" rel="external">
          Rifabutin
         </a>
         – Rifabutin (used in the treatment of atypical mycobacterial infection) appears to be frequently associated with a florid anterior uveitis [
         <a href="#rid48">
          48
         </a>
         ]. The inflammation resolves despite continuing the medication, suggesting that the inflammation may result from a hypersensitivity reaction triggered in part by the death of mycobacterial organisms induced by the antibiotic.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9264" href="/z/d/drug information/9264.html" rel="external">
          Cidofovir
         </a>
         – Cidofovir, an antiviral drug that can be injected intravitreally, is also frequently associated with uveitis [
         <a href="#rid49">
          49,50
         </a>
         ]. Other drugs administered by intravitreal injection and associated with eye inflammation include
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         [
         <a href="#rid51">
          51
         </a>
         ] and
         <a class="drug drug_general" data-topicid="122820" href="/z/d/drug information/122820.html" rel="external">
          brolucizumab
         </a>
         [
         <a href="#rid52">
          52
         </a>
         ], a light chain monoclonal antibody that inhibits vascular endothelial growth factor.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fluoroquinolone antibiotics – Several fluoroquinolone antibiotics have been associated with an increased risk of uveitis, including
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         and
         <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">
          ciprofloxacin
         </a>
         , but not
         <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">
          levofloxacin
         </a>
         [
         <a href="#rid53">
          53
         </a>
         ]. Moxifloxacin is implicated in a rare form of uveitis characterized by some loss of pigment in the iris [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bisphosphonates – Bisphosphonates, especially when administered intravenously, are an infrequent cause of uveitis [
         <a href="#rid55">
          55
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/104424.html" rel="external">
          "Risks of bisphosphonate therapy in patients with osteoporosis", section on 'Ocular side effects'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         BRAF kinase inhibitors –
         <a class="drug drug_general" data-topicid="16798" href="/z/d/drug information/16798.html" rel="external">
          Vemurafenib
         </a>
         and
         <a class="drug drug_general" data-topicid="89686" href="/z/d/drug information/89686.html" rel="external">
          dabrafenib
         </a>
         , which are inhibitors of BRAF kinase that are used for the treatment of metastatic melanoma, may infrequently cause uveitis. (See
         <a class="medical medical_review" href="/z/d/html/15408.html" rel="external">
          "Systemic treatment of metastatic melanoma with BRAF and other molecular alterations", section on 'Toxicities of BRAF and MEK inhibitors'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cancer immunotherapy – Immune checkpoint inhibitor immunotherapy, including the use of
         <a class="drug drug_general" data-topicid="16084" href="/z/d/drug information/16084.html" rel="external">
          ipilimumab
         </a>
         ,
         <a class="drug drug_general" data-topicid="96957" href="/z/d/drug information/96957.html" rel="external">
          pembrolizumab
         </a>
         ,
         <a class="drug drug_general" data-topicid="108314" href="/z/d/drug information/108314.html" rel="external">
          atezolizumab
         </a>
         ,
         <a class="drug drug_general" data-topicid="112994" href="/z/d/drug information/112994.html" rel="external">
          durvalumab
         </a>
         , and
         <a class="drug drug_general" data-topicid="98764" href="/z/d/drug information/98764.html" rel="external">
          nivolumab
         </a>
         , has been associated with uveitis and other ocular inflammatory manifestations and is discussed in more detail separately [
         <a href="#rid56">
          56
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/96368.html" rel="external">
          "Toxicities associated with immune checkpoint inhibitors", section on 'Eye'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Uveitis syndromes usually restricted to the eye
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although many forms of uveitis are associated with systemic inflammatory or infectious disease, a variety of uveitis syndromes generally occur without extraocular or infectious involvement  (
         <a class="graphic graphic_table graphicRef75844" href="/z/d/graphic/75844.html" rel="external">
          table 1B
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pars planitis
         </strong>
         –
         <strong>
         </strong>
         Pars planitis is a relatively common form of uveitis characterized by the presence of inflammatory debris over the pars plana, the portion of the eye between the retina and the ciliary body [
         <a href="#rid57">
          57
         </a>
         ]. Thus, pars planitis is an anatomic description of the location of inflammation. Pars planitis is sometimes called peripheral uveitis and is a subset of intermediate uveitis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Pars planitis is usually not associated with a systemic disease, but it can be a manifestation of systemic conditions including MS [
         <a href="#rid58">
          58
         </a>
         ] or sarcoidosis [
         <a href="#rid59">
          59
         </a>
         ]. Because of its association with MS, an evaluation to identify evidence for MS may be appropriate in some patients. (See
         <a class="medical medical_review" href="/z/d/html/1689.html" rel="external">
          "Manifestations of multiple sclerosis in adults"
         </a>
         and
         <a class="local">
          'Diagnostic testing'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Birdshot chorioretinitis
         </strong>
         – Birdshot chorioretinitis is a chronic, bilateral, posterior uveitis associated with multiple focal inflammatory aggregates that resemble tiny birdshot pellets  (
         <a class="graphic graphic_picture graphicRef58904" href="/z/d/graphic/58904.html" rel="external">
          picture 11
         </a>
         ) [
         <a href="#rid60">
          60,61
         </a>
         ]. Ninety-five percent of patients with this disorder possess the HLA-A29 antigen [
         <a href="#rid62">
          62
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sympathetic ophthalmia
         </strong>
         – Sympathetic ophthalmia is an inflammation of the contralateral eye of a small percentage of patients who have experienced penetrating trauma to one eye [
         <a href="#rid63">
          63
         </a>
         ]. Multiple surgeries to either eye are another recognized, rare trigger for sympathetic ophthalmia. It usually begins as an anterior uveitis several weeks to a year following the trauma and is thought to result from an autoimmune response to a retinal antigen [
         <a href="#rid64">
          64
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Post-traumatic inflammation
         </strong>
         – Most experts do not include trauma as a category of uveitis, although cataract surgery and other intraocular surgeries routinely do cause some postoperative inflammation that is generally self-limited. Since cataract surgery is performed in the United States more than 1 million times annually, some would argue that cataract surgery is the most common cause of uveitis. This form of post-traumatic inflammation should not be confused with sympathetic ophthalmia, which is immune-mediated, persistent, and often severe, but much less common than routine postsurgical inflammation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Immune recovery uveitis
         </strong>
         – Immune recovery uveitis is a phenomenon most often recognized in association with the use of antiretroviral therapy (ART) for HIV infection. This phenomenon is referred to as the immune reconstitution inflammatory syndrome (IRIS). As this treatment allows recovery of CD4 T cell counts, some patients with prior CMV retinitis develop intraocular inflammation, presumably due to an enhanced immune response. (See
         <a class="medical medical_review" href="/z/d/html/3746.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of AIDS-related cytomegalovirus retinitis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3762.html" rel="external">
          "Immune reconstitution inflammatory syndrome", section on 'IRIS associated with cytomegalovirus'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Idiopathic
         </strong>
         – Approximately 30 percent of patients with uveitis have disease that does not fit into any apparent etiologic category [
         <a href="#rid25">
          25,65
         </a>
         ]. Many patients with this disorder, sometimes called idiopathic or undifferentiated uveitis, may have a form of sarcoid that is limited to the eye [
         <a href="#rid66">
          66
         </a>
         ]. Viral infections may account for some cases of this form of uveitis [
         <a href="#rid67">
          67
         </a>
         ] (see
         <a class="local">
          'Systemic inflammatory diseases'
         </a>
         above and
         <a class="local">
          'Infectious causes'
         </a>
         above). Transcriptomic analysis of gene expression in peripheral blood is being explored as a means to subclassify idiopathic uveitis [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H84697374">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Symptoms and findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         The symptoms of uveitis, which are all nonspecific, depend upon the portion of the uveal tract that is involved (see
         <a class="local">
          'Differential diagnosis'
         </a>
         below). Findings also differ depending upon the location of the involvement, and visual loss may occur with anterior, intermediate, or posterior involvement. Anterior uveitis is about four times more common than posterior uveitis [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anterior uveitis
         </strong>
         –
         <strong>
         </strong>
         Anterior uveitis may produce pain and redness, although these symptoms are minimal if inflammation begins insidiously (eg, in juvenile idiopathic arthritis [JIA]). In anterior uveitis (iritis), the redness, if present, is primarily noted at the limbus (the junction between the cornea and the sclera); such patients often have a constricted pupil and pain. The degree of visual loss associated with anterior uveitis is variable.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The presence of leukocytes in the anterior chamber of the eye on slit lamp examination is characteristic of anterior uveitis, but is nonspecific (see
         <a class="local">
          'Differential diagnosis'
         </a>
         below). Leukocytes are not normally found in the aqueous humor that fills the space between the cornea and the lens. A haze, described by ophthalmologists as "flare," may also be appreciated by slit-lamp examination and reflects protein accumulation in the aqueous humor secondary to disruption of the blood aqueous barrier.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Posterior and intermediate uveitis
         </strong>
         – In contrast to anterior uveitis, posterior or intermediate uveitis is more likely to be painless, but may result in nonspecific visual changes such as floaters and/or reduced visual acuity. Redness of the eye is not a prominent feature of posterior inflammation unless there is an accompanying anterior uveitis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In posterior or intermediate uveitis, direct visualization of active chorioretinal inflammation and/or leukocytes in the vitreous humor can be detected on ophthalmic examination. Complete examination of the eye posterior to the lens usually includes a technique called scleral depression. This maneuver allows the examiner to look for an inflammatory exudate over the pars plana, the portion of the eye just between the retina and the ciliary body. Exudates or "snowbanks" are characteristic of a relatively common form of intermediate uveitis known as pars planitis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Panuveitis
         </strong>
         – In patients with panuveitis, inflammation is detected simultaneously in the anterior chamber, vitreous, and retina or choroid either by use of a slit lamp in conjunction with special lenses to focus the beam posterior to the lens or with an indirect ophthalmoscope and a handheld lens.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H84697294">
         <span class="h2">
          Complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Uveitis can be associated with a variety of complications. Evaluation by an ophthalmologist is important in the recognition and management of potential complications of uveitis. Such complications may include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Band keratopathy (deposition of calcium in the epithelium of the cornea).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Posterior synechiae (adhesion of the iris to the lens which lies posterior to it).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cataract (resulting from inflammation in some patients or glucocorticoid treatment in others). (See
         <a class="medical medical_review" href="/z/d/html/6904.html" rel="external">
          "Cataract in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intraocular hypertension (OHT) and glaucoma. (See
         <a class="medical medical_review" href="/z/d/html/6909.html" rel="external">
          "Open-angle glaucoma: Epidemiology, clinical presentation, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6903.html" rel="external">
          "Angle-closure glaucoma"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cystoid macular edema (fluid accumulation in the area of central vision). Optical coherence tomography is frequently used to detect cystoid macular edema.
        </p>
        <p>
        </p>
        <p>
         The risk of specific complications can differ, depending on the underlying illness and the treatment. As examples, the uveitis associated with JIA is frequently associated with band keratopathy (see
         <a class="local">
          'Systemic inflammatory diseases'
         </a>
         above); and in one study OHT occurred in half of patients with varicella zoster virus-associated iridocyclitis, but in only about a quarter of patients with Behçet syndrome, acute anterior uveitis, or sarcoidosis [
         <a href="#rid70">
          70
         </a>
         ]. The OHT in patients with nongranulomatous uveitis was mainly glucocorticoid-induced open-angle OHT, with some cases of angle-closure OHT caused by pupillary block; in granulomatous uveitis it was typically inflammation-induced OHT with no pupillary block-related angle-closure OHT.
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          DIAGNOSIS AND REFERRAL
         </span>
        </p>
        <p class="headingAnchor" id="H4248901190">
         <span class="h2">
          When to refer to an ophthalmologist
         </span>
         <span class="headingEndMark">
          —
         </span>
         Referral to an expert in ophthalmology for slit-lamp examination and a dilated fundus examination is required for the diagnosis of uveitis in patients suspected of uveal tract inflammation based upon their symptoms and findings or the presence of other illnesses strongly associated with uveitis. (See
         <a class="medical medical_review" href="/z/d/html/259.html" rel="external">
          "Slit lamp examination"
         </a>
         and
         <a class="local">
          'Symptoms and findings'
         </a>
         above and
         <a class="local">
          'Etiology'
         </a>
         above.)
        </p>
        <p>
         The mnemonic RSVP can be useful in guiding when to refer a patient to an ophthalmologist. R stands for redness, which for this purpose should be persistent, since redness is common and is often a manifestation of problems that usually do not threaten vision such as ocular allergy, dry eye, or mild chemical irritation (see
         <a class="local">
          'Differential diagnosis'
         </a>
         below). S stands for sensitivity to light. Although this is not specific for acute anterior uveitis (it frequently occurs, for example, with migraine headache), it might indicate intraocular inflammation. V stands for visual change. Anyone complaining of visual loss or obscuration needs an ophthalmic exam or sometimes a neurologic exam. The P is for pain, which is prominent in acute anterior uveitis but generally absent in more common diseases such as dry eye or allergy. In general, symptoms that begin acutely require prompt ophthalmic evaluation, while there is less urgency to assess a chronic complaint.
        </p>
        <p class="headingAnchor" id="H3185467976">
         <span class="h2">
          Diagnostic evaluation and findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with uveitis, leukocytes are seen in the anterior chamber of the eye on slit lamp examination. In comparison with anterior uveitis, posterior or intermediate uveitis is diagnosed by direct visualization of active chorioretinal inflammation and/or by detection of leukocytes in the vitreous humor on ophthalmic examination.
        </p>
        <p>
         The diagnosis of panuveitis is made when inflammation is detected simultaneously in the anterior chamber, vitreous, and retina or choroid. These findings are identified either by use of a slit lamp in conjunction with special lenses to focus the beam posterior to the lens or with an indirect ophthalmoscope and a handheld lens. Complete examination of the eye posterior to the lens usually includes a technique called scleral depression. This maneuver allows the examiner to look for an inflammatory exudate over the pars plana, the portion of the eye just between the retina and the ciliary body, to determine if findings of pars planitis are present.
        </p>
        <p>
         A thorough ophthalmic examination can generally exclude alternative diagnoses that can result in similar symptoms and general examination findings.
        </p>
        <p class="headingAnchor" id="H84697132">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some of the symptoms or findings seen in uveitis may also occur in other conditions, and a number of noninfectious processes, sometimes termed masquerade syndromes, can be mistaken for an inflammatory process involving the uveal tract; most of these latter conditions are malignancies, and the most common is a B-cell lymphoma  (
         <a class="graphic graphic_table graphicRef64117" href="/z/d/graphic/64117.html" rel="external">
          table 2
         </a>
         ). The differential diagnosis includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis by symptom or finding:
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Red eye
         </strong>
         – Although many patients with anterior uveitis have a red eye, uveitis can generally be distinguished from other causes of a red eye, such as corneal inflammation (keratitis), conjunctival inflammation (conjunctivitis), blood vessel inflammation in the episclera or sclera (episcleritis and scleritis, respectively), and acute closed-angle glaucoma, on ophthalmic examination. In iritis (anterior uveitis), the redness is primarily noted at the limbus (the junction between the cornea and the sclera), in association with a constricted pupil and pain. The evaluation and differential diagnosis of the red eye is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6900.html" rel="external">
          "The red eye: Evaluation and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cells in the anterior chamber
         </strong>
         – Leukocytes in the anterior chamber of the eye are characteristic of anterior uveitis (iritis), although other conditions may cause white cells in the anterior chamber; these include a bacterial corneal ulcer and scleritis, which can often be differentiated from uveitis on a careful ophthalmic examination, aided by slit-lamp examination. However, in some patients, uveitis may occur in association with scleritis. White cells in the anterior chamber may also occur due to a "spillover" phenomenon arising from inflammation in the posterior compartment of the eye. Cellular infiltration without inflammation may occur due to hematologic and lymphoproliferative disorders as well. Occasionally, pigmented cells in the anterior chamber as in pigment dispersion syndrome could be mistaken for leukocytes. (See
         <a class="medical medical_review" href="/z/d/html/5599.html" rel="external">
          "Clinical manifestations and diagnosis of scleritis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6900.html" rel="external">
          "The red eye: Evaluation and management", section on 'Bacterial keratitis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6897.html" rel="external">
          "Corneal abrasions and corneal foreign bodies: Clinical manifestations and diagnosis", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Floaters
         </strong>
         – Patients with posterior or intermediate uveitis may have floaters, but floaters or debris in the visual field may also result from noninflammatory processes such as normal aging, in which other findings suggesting uveitis will be absent. Floaters can also occur in patients with a retinal detachment or tear, which can be distinguished from uveitis on the dilated retinal examination with indirect ophthalmoscopy and slit lamp examination. (See
         <a class="local">
          'Symptoms and findings'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/6910.html" rel="external">
          "Retinal detachment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Masquerade syndromes:
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Intraocular lymphoma
         </strong>
         – The most common malignancy that presents like uveitis in adults is lymphoma, typically a B-cell type that is confined to the eye and the central nervous system  (
         <a class="graphic graphic_picture graphicRef55813" href="/z/d/graphic/55813.html" rel="external">
          picture 12
         </a>
         ). The eye disease is usually bilateral and generally presents as the insidious onset of visual obscuration, such as floaters. Ocular lymphoma may be difficult to diagnose, but should be suspected when inflammation is refractory to glucocorticoids, when neurological symptoms are present, or when bilateral posterior eye inflammation has begun after age 45. If lymphoma is suspected, the ophthalmology specialist may obtain a sample for vitreous humor cytology to exclude ocular lymphoma or perform a retinal biopsy. (See
         <a class="medical medical_review" href="/z/d/html/4693.html" rel="external">
          "Primary central nervous system lymphoma: Clinical features, diagnosis, and extent of disease evaluation", section on 'Eyes'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Others
         </strong>
         – Several other conditions, both malignant and nonmalignant, may also infrequently mimic uveitis  (
         <a class="graphic graphic_table graphicRef64117" href="/z/d/graphic/64117.html" rel="external">
          table 2
         </a>
         ). These conditions are generally differentiated from uveitis on ophthalmic examination.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          POSTDIAGNOSTIC APPROACH
         </span>
         <span class="headingEndMark">
          —
         </span>
         A detailed history and general physical examination, with particular attention to potential causes of uveitis (see
         <a class="local">
          'Etiology'
         </a>
         above), will provide complementary information to that gained from the slit-lamp and dilated funduscopic examination that is needed to document and characterize uveitis. Establishing an etiology can help to determine the most appropriate treatment (see
         <a class="local">
          'History and examination'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/5592.html" rel="external">
          "Uveitis: Treatment"
         </a>
         ). In patients in whom the etiology remains uncertain based upon the history and examination alone, selected laboratory testing may help to elucidate the cause. (See
         <a class="local">
          'Diagnostic testing'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H55582701">
         <span class="h2">
          History and examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         A detailed history is the most important step in the initial evaluation of a patient presenting with symptoms suggesting uveitis. In general, when uveitis is related to a systemic disorder, the associated diagnosis will be apparent at the time of the initial history and physical examination. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with anterior uveitis should be queried regarding features of spondyloarthritis (SpA), such as low back pain, typically before age 45 and especially if lasting more than three months; joint pain or swelling, especially for which care was sought with a clinician; or a family history of SpA. Answering yes to either of the first two questions (ie, back pain or joint pain), followed by testing that is positive for human leukocyte antigen (HLA)-B27, had high specificity and sensitivity for the diagnosis of SpA in patients with acute, unilateral anterior uveitis of previously unknown etiology [
         <a href="#rid23">
          23
         </a>
         ]. SpA was identified by this strategy in about 40 percent of these patients. (See
         <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">
          "Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Further support for this approach comes from a large collaborative study in Spain by rheumatologists and ophthalmologists in which about 90 percent of patients with acute anterior uveitis of unknown etiology who were HLA-B27-positive had sufficient additional features on history and examination to establish a diagnosis of axial or peripheral SpA [
         <a href="#rid71">
          71
         </a>
         ]. A diagnosis of SpA could also be made in about 30 percent of patients who were HLA-B27-negative.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The history should also include questions regarding risk factors for HIV infection. Patients with HIV infection are at increased risk for several infectious causes of uveitis, including cytomegalovirus (CMV) retinitis. (See
         <a class="local">
          'Infectious causes'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/3724.html" rel="external">
          "The natural history and clinical features of HIV infection in adults and adolescents"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3746.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of AIDS-related cytomegalovirus retinitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with pars planitis, particular attention should be given in the history and physical examination to features suggestive of multiple sclerosis, which is present in increased frequency in such patients. (See
         <a class="local">
          'Drugs and hypersensitivity reactions'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/1689.html" rel="external">
          "Manifestations of multiple sclerosis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with panuveitis, the differential diagnosis includes Behçet syndrome, Vogt-Koyanagi-Harada (VKH) syndrome, sarcoidosis, sympathetic ophthalmia, and infection. (See
         <a class="local">
          'Systemic inflammatory diseases'
         </a>
         above and
         <a class="local">
          'Infectious causes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Diagnostic testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Only limited diagnostic testing is useful when an associated condition is not apparent despite a thorough medical history and physical examination (see
         <a class="local">
          'Testing when no potential cause is apparent'
         </a>
         below). In patients in whom the history and examination does suggest a possible cause, diagnostic testing, which is focused upon confirming or excluding the suspected etiology, is warranted for confirmation of the specific diagnosis (see
         <a class="local">
          'Etiology'
         </a>
         above and
         <a class="local">
          'History and examination'
         </a>
         above and
         <a class="local">
          'Testing when clinical features suggest an etiology'
         </a>
         below). In either situation, the use of multiple screening tests (a "shotgun approach") should be avoided.
        </p>
        <p>
         The location, acuity, and response to therapy can help guide diagnostic considerations and testing. For example, acute unilateral anterior uveitis suggests the possibility of a spondyloarthropathy, about which patients should be specifically questioned to identify whether symptoms warranting further evaluation may be present (see
         <a class="local">
          'History and examination'
         </a>
         above), while bilateral chronic anterior and posterior uveitis may suggest sarcoidosis.
        </p>
        <p class="headingAnchor" id="H150162961">
         <span class="h3">
          Testing when no potential cause is apparent
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with uveitis in whom the etiology remains unknown despite a detailed history and thorough examination, only limited testing is generally indicated. The location and response to therapy may help guide diagnostic considerations and testing. We perform two tests in this population:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Plain radiography of the chest to seek evidence of pulmonary sarcoidosis or infection associated with uveitis, such as tuberculosis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serologic test for syphilis, which may be clinically silent
        </p>
        <p>
        </p>
        <p>
         We perform selected testing in uveitis of unknown etiology because the underlying conditions may otherwise be clinically silent and treatment may be required, even though the likelihood of these diagnoses may be low [
         <a href="#rid72">
          72,73
         </a>
         ]. A careful history and examination in patients with acute noninfectious anterior uveitis frequently reveals evidence of SpA that had not previously been recognized. (See
         <a class="local">
          'History and examination'
         </a>
         above.)
        </p>
        <p>
         Sarcoidosis and syphilis are among the most common of the disorders causing uveitis in which the systemic (non-ocular) manifestations of the underlying disease may be clinically inapparent. Patients with ocular sarcoidosis should be questioned about cardiac symptoms such as presyncope or palpitations and may benefit from cardiology evaluation [
         <a href="#rid74">
          74
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4353.html" rel="external">
          "Clinical manifestations and diagnosis of sarcoidosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/91259.html" rel="external">
          "Overview of extrapulmonary manifestations of sarcoidosis"
         </a>
         .)
        </p>
        <p>
         The frequency with which sarcoidosis is a cause of what would otherwise be labeled idiopathic uveitis is illustrated by a study that found that 57 percent of women with uveitis between the ages of 61 and 83 had hilar adenopathy on chest computed tomography (CT) scanning, although routine radiographs were unremarkable [
         <a href="#rid66">
          66
         </a>
         ]. Although extrapolation of these findings to other patient populations is uncertain, a CT scan of the chest may be of benefit in some patients with a normal chest radiograph and uveitis in whom the diagnosis is unclear. The diagnostic value of the CT scan must be weighed against the risks from the radiation exposure from the study. As an example, a patient older than 60 with ophthalmic examination findings that suggest granulomatous inflammation, who has a normal chest radiograph and no other known etiology for the uveitis, is a good candidate for a chest CT scan. By contrast, a patient who is 30 years old with ocular findings described by an ophthalmologist as nongranulomatous might also have sarcoidosis, but the risk of the radiation and the low probability that the eye disease is sarcoid would dissuade the author from ordering a chest CT scan in this setting. Cardiac sarcoidosis is being increasingly recognized thanks to imaging modalities such as cardiac magnetic resonance imaging (MRI) or positron emission tomography (PET) scanning. Cardiac sarcoidosis can cause arrhythmia and may cause sudden death. Uveitis is frequently the first recognized symptom of sarcoidosis.
        </p>
        <p class="headingAnchor" id="H71420432">
         <span class="h3">
          Testing when clinical features suggest an etiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnostic testing should be directed to the suspected cause when there is clinical information that suggests one of the myriad conditions that may be associated with uveitis. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with acute anterior uveitis and a history of symptoms or findings that might suggest SpA (eg, inflammatory back pain, enthesitis [eg, Achilles tendonitis or plantar fasciitis], dactylitis [ie, a "sausage digit"], or a family history of SpA) HLA-B27 testing and further evaluation of a SpA is useful to assess the possible diagnosis of SpA [
         <a href="#rid23">
          23
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">
          "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7795.html" rel="external">
          "Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         By using an algorithm to evaluate patients with acute anterior uveitis in a Dublin emergency department, one group found that 40 percent of these patients who did not previously have a known diagnosis of ankylosing spondylitis had evidence of a SpA [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Testing for tuberculosis may be of value in patients at increased risk for tuberculous uveitis, such as patients from tuberculosis-endemic regions [
         <a href="#rid75">
          75-77
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/115049.html" rel="external">
          "Tuberculosis infection (latent tuberculosis) in adults: Approach to diagnosis (screening)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         HIV testing is
         <strong>
          not
         </strong>
         routinely obtained in evaluating patients with uveitis, but should be obtained in patients with a known opportunistic infection or a presumed infectious or immunologic cause of uveitis that is not responding to therapy in the expected manner. HIV testing may also be indicated in uveitis patients with risk factors for HIV infection. Opportunistic infections, such as CMV retinitis, should be considered in immunocompromised patients. (See
         <a class="medical medical_review" href="/z/d/html/3724.html" rel="external">
          "The natural history and clinical features of HIV infection in adults and adolescents"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3736.html" rel="external">
          "Screening and diagnostic testing for HIV infection"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3746.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of AIDS-related cytomegalovirus retinitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serologic testing for systemic lupus erythematosus and for Lyme disease should be performed in patients with signs or symptoms of these conditions but are generally
         <strong>
          not
         </strong>
         suggested in the absence of other clinical signs or symptoms of these disorders [
         <a href="#rid75">
          75,78
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4668.html" rel="external">
          "Clinical manifestations and diagnosis of systemic lupus erythematosus in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7914.html" rel="external">
          "Diagnosis of Lyme disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with pars planitis, because of its association with multiple sclerosis (MS), a thorough neurologic history and examination are indicated, and MRI of the brain may also be appropriate in these patients [
         <a href="#rid79">
          79
         </a>
         ]. The author's preference is to obtain an MRI only in those patients with neurological symptoms.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients who have had intraocular lens implantation temporally related to the onset of uveitis, vitreous humor aspiration and culture might be indicated to determine if infection is present.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with intraocular inflammation and suspected infectious retinitis, early polymerase chain reaction testing of ocular fluid for specific infections such as herpes zoster or herpes simplex can be useful in making a timely diagnosis [
         <a href="#rid6">
          6,80
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Ocular manifestations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8327.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes zoster"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3058500667">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118570.html" rel="external">
          "Society guideline links: Uveitis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16819822">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/82908.html" rel="external">
          "Patient education: Uveitis (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/82974.html" rel="external">
          "Patient education: Chorioretinitis (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definitions
         </strong>
         – The presence of leukocytes in the anterior chamber of the eye is characteristic of anterior uveitis but may also occur due to an infection of the cornea or a "spillover" phenomenon arising from inflammation in the posterior compartment of the eye. The presence of leukocytes in the vitreous humor and evidence of active chorioretinal inflammation are diagnostic of intermediate uveitis and posterior uveitis, respectively. Panuveitis is defined as simultaneous inflammation in the anterior chamber, vitreous humor, and retina or choroid  (
         <a class="graphic graphic_figure graphicRef57690" href="/z/d/graphic/57690.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="local">
          'Definitions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiology
         </strong>
         – Uveitis frequently occurs in association with other systemic medical conditions, especially infections and inflammatory diseases, but may occur as an isolated process. Approximately 30 percent of patients with uveitis do not have an identifiable infectious etiology, a distinct pattern such as pars planitis, or any apparent associated systemic disease. (See
         <a class="local">
          'Etiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Infectious causes
         </strong>
         – The infectious causes of uveitis include bacterial and spirochetal diseases, viral diseases, fungal infections, and parasitic infections  (
         <a class="graphic graphic_table graphicRef61247" href="/z/d/graphic/61247.html" rel="external">
          table 1A
         </a>
         ). Cytomegalovirus (CMV) infection is an important etiology in patients with HIV/AIDS. Ocular toxoplasmosis can affect both normal and immunocompromised hosts but is far more common in immune competent patients, in contrast to central nervous system toxoplasmosis that is seen almost exclusively in the immune-compromised. (See
         <a class="local">
          'Infectious causes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Noninfectious (systemic inflammatory diseases, drugs, and hypersensitivity) causes
         </strong>
         – Various systemic inflammatory diseases are associated with uveitis, including spondyloarthritis (SpA, eg, ankylosing spondylitis, psoriatic arthritis, and reactive arthritis), inflammatory bowel disease (IBD), sarcoidosis, Behçet syndrome, and juvenile idiopathic arthritis (JIA). Multiple sclerosis (MS), more commonly associated with optic neuritis, may also cause uveitis. Several medications may cause uveitis. (See
         <a class="local">
          'Systemic inflammatory diseases'
         </a>
         above and
         <a class="local">
          'Drugs and hypersensitivity reactions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Symptoms
         </strong>
         – Uveitis symptoms depend on the portion of the uveal tract affected. Anterior uveitis may produce pain and redness; posterior or intermediate uveitis is more likely to be painless, but is often associated with floaters and/or some degree of visual loss. Visual loss may occur with anterior, intermediate, or posterior involvement. (See
         <a class="local">
          'Symptoms and findings'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis and diagnostic techniques
         </strong>
         – Slit lamp and funduscopic examination are necessary to establish the presence of uveitis. Examination should include scleral depression to assess for inflammation just posterior to the lens (the pars plana of the uveal tract). (See
         <a class="local">
          'Diagnosis and referral'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – Cellular infiltration that is not due to inflammation may occur in hematologic and lymphoproliferative disorders. Central nervous system lymphoma may "masquerade" as uveitis. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postdiagnostic evaluation
         </strong>
         – A detailed medical history is the most important step to diagnose an associated systemic disease. A chest radiograph and serologic test for syphilis should be performed in patients for whom there is no apparent cause. Further diagnostic testing may include chest CT scan and evaluation to exclude other infections, systemic inflammatory disease, or MS  (
         <a class="graphic graphic_table graphicRef55902" href="/z/d/graphic/55902.html" rel="external">
          table 1C
         </a>
         ). Because of a strong association between uveitis affecting the pars plana (pars planitis) and MS, particular attention should be given to the neurologic history in patients with pars planitis. (See
         <a class="local">
          'Postdiagnostic approach'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1676154191">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges James T Rosenbaum, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wertheim MS, Mathers WD, Planck SJ, et al. In vivo confocal microscopy of keratic precipitates. Arch Ophthalmol 2004; 122:1773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yeh S, Forooghian F, Suhler EB. Implications of the Pacific Ocular Inflammation uveitis epidemiology study. JAMA 2014; 311:1912.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yuen BG, Tham VM, Browne EN, et al. Association between Smoking and Uveitis: Results from the Pacific Ocular Inflammation Study. Ophthalmology 2015; 122:1257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin P, Loh AR, Margolis TP, Acharya NR. Cigarette smoking as a risk factor for uveitis. Ophthalmology 2010; 117:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doan T, Sahoo MK, Ruder K, et al. Comprehensive pathogen detection for ocular infections. J Clin Virol 2021; 136:104759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Radosavljevic A, Agarwal M, Chee SP, Zierhut M. Epidemiology of Viral Induced Anterior Uveitis. Ocul Immunol Inflamm 2022; 30:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiss MJ, Velazquez N, Hofeldt AJ. Serologic tests in the diagnosis of presumed toxoplasmic retinochoroiditis. Am J Ophthalmol 1990; 109:407.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 2002; 109:869.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Margo CE, Hamed LM. Ocular syphilis. Surv Ophthalmol 1992; 37:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suhler EB, Lauer AK, Rosenbaum JT. Prevalence of serologic evidence of cat scratch disease in patients with neuroretinitis. Ophthalmology 2000; 107:871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kibadi K, Mupapa K, Kuvula K, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis 1999; 179 Suppl 1:S13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Varkey JB, Shantha JG, Crozier I, et al. Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med 2015; 372:2423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mattia JG, Vandy MJ, Chang JC, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis 2016; 16:331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Paula Freitas B, de Oliveira Dias JR, Prazeres J, et al. Ocular Findings in Infants With Microcephaly Associated With Presumed Zika Virus Congenital Infection in Salvador, Brazil. JAMA Ophthalmol 2016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Furtado JM, Espósito DL, Klein TM, et al. Uveitis Associated with Zika Virus Infection. N Engl J Med 2016; 375:394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kodati S, Palmore TN, Spellman FA, et al. Bilateral posterior uveitis associated with Zika virus infection. Lancet 2017; 389:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang Y, Stewart JM. Retinal and choroidal manifestations of COVID-19. Curr Opin Ophthalmol 2021; 32:536.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lafay C, Assad Z, Ouldali N, et al. Increased Incidence of Pediatric Uveitis Associated with the COVID-19 Pandemic Occurring Before COVID-19 Vaccine Implementation: A Time-Series Analysis. J Pediatr 2023; 263:113682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Testi I, Brandão-de-Resende C, Agrawal R, et al. Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect 2022; 12:4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol 2004; 138:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenbaum JT. Acute anterior uveitis and spondyloarthropathies. Rheum Dis Clin North Am 1992; 18:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haroon M, O'Rourke M, Ramasamy P, et al. A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool). Ann Rheum Dis 2015; 74:1990.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muñoz-Fernández S, de Miguel E, Cobo-Ibáñez T, et al. Enthesis inflammation in recurrent acute anterior uveitis without spondylarthritis. Arthritis Rheum 2009; 60:1985.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenbaum JT. Uveitis. An internist's view. Arch Intern Med 1989; 149:1173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol 1987; 103:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol 1992; 76:137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol 1978; 86:648.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           James DG. Ocular sarcoidosis. Ann N Y Acad Sci 1986; 465:551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karma A, Huhti E, Poukkula A. Course and outcome of ocular sarcoidosis. Am J Ophthalmol 1988; 106:467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lambert JR, Wright V. Eye inflammation in psoriatic arthritis. Ann Rheum Dis 1976; 35:354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lyons JL, Rosenbaum JT. Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 1997; 115:61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paiva ES, Macaluso DC, Edwards A, Rosenbaum JT. Characterisation of uveitis in patients with psoriatic arthritis. Ann Rheum Dis 2000; 59:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malinowski SM, Pulido JS, Goeken NE, et al. The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology 1993; 100:1199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Messenger W, Hildebrandt L, Mackensen F, et al. Characterisation of uveitis in association with multiple sclerosis. Br J Ophthalmol 2015; 99:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 1991; 109:682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sakata VM, da Silva FT, Hirata CE, et al. Diagnosis and classification of Vogt-Koyanagi-Harada disease. Autoimmun Rev 2014; 13:550.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greco A, Fusconi M, Gallo A, et al. Vogt-Koyanagi-Harada syndrome. Autoimmun Rev 2013; 12:1033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang XY, Wang XM, Hu TS. Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1992; 113:567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990; 335:1078.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mamo JG. The rate of visual loss in Behçet's disease. Arch Ophthalmol 1970; 84:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenbaum JT, Bennett RM. Chronic anterior and posterior uveitis and primary Sjögren's syndrome. Am J Ophthalmol 1987; 104:346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gold DH, Morris DA, Henkind P. Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 1972; 56:800.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M. Lupus retinopathy. Patterns, associations, and prognosis. Arthritis Rheum 1988; 31:1105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenbaum JT, Ku J, Ali A, et al. Patients with retinal vasculitis rarely suffer from systemic vasculitis. Semin Arthritis Rheum 2012; 41:859.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenbaum JT, Roman-Goldstein S, Lindquist GR, Rosenbaum RB. Uveitis and central nervous system vasculitis. J Rheumatol 1998; 25:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Standardization of Uveitis Nomenclature (SUN) Working Group. Development of Classification Criteria for the Uveitides. Am J Ophthalmol 2021; 228:96.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shafran SD, Deschênes J, Miller M, et al. Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network. N Engl J Med 1994; 330:438.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ambati J, Wynne KB, Angerame MC, Robinson MR. Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis. Br J Ophthalmol 1999; 83:1153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bainbridge JW, Raina J, Shah SM, et al. Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS. Eye (Lond) 1999; 13 ( Pt 3a):353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Witkin AJ, Chang DF, Jumper JM, et al. Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: Clinical Characteristics of 36 Eyes. Ophthalmology 2017; 124:583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dugel PU, Koh A, Ogura Y, et al. HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology 2020; 127:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eadie B, Etminan M, Mikelberg FS. Risk for uveitis with oral moxifloxacin: a comparative safety study. JAMA Ophthalmol 2015; 133:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wefers Bettink-Remeijer M, Brouwers K, van Langenhove L, et al. Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye (Lond) 2009; 23:2260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xie JS, Kaplan AJ. Anterior uveitis and diffuse scleritis after pamidronate infusion. CMAJ 2023; 195:E1722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dow ER, Yung M, Tsui E. Immune Checkpoint Inhibitor-associated Uveitis: Review of Treatments and Outcomes. Ocul Immunol Inflamm 2021; 29:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malinowski SM, Pulido JS, Folk JC. Long-term visual outcome and complications associated with pars planitis. Ophthalmology 1993; 100:818.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zein G, Berta A, Foster CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 2004; 12:137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bregerbc, Leopold IH. The incidence of uveitis in multiple sclerosis. Am J Ophthalmol 1966; 62:540.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Priem HA, Oosterhuis JA. Birdshot chorioretinopathy: clinical characteristics and evolution. Br J Ophthalmol 1988; 72:646.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shao EH, Menezo V, Taylor SR. Birdshot chorioretinopathy. Curr Opin Ophthalmol 2014; 25:488.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LeHoang P, Ozdemir N, Benhamou A, et al. HLA-A29.2 subtype associated with birdshot retinochoroidopathy. Am J Ophthalmol 1992; 113:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang GC, Young LH. Sympathetic ophthalmia. Semin Ophthalmol 2011; 26:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lubin JR, Albert DM, Weinstein M. Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of 105 cases (1913--1978). Ophthalmology 1980; 87:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenbaum JT. Nibbling away at the diagnosis of idiopathic uveitis. JAMA Ophthalmol 2015; 133:146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaiser PK, Lowder CY, Sullivan P, et al. Chest computerized tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol 2002; 133:499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Groot-Mijnes JD, de Visser L, Zuurveen S, et al. Identification of new pathogens in the intraocular fluid of patients with uveitis. Am J Ophthalmol 2010; 150:628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenbaum JT, Harrington CA, Searles RP, et al. Revising the Diagnosis of Idiopathic Uveitis by Peripheral Blood Transcriptomics. Am J Ophthalmol 2021; 222:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Darrell RW, Wagener HP, Kurland LT. Epidemiology of uveitis. Incidence and prevalence in a small urban community. Arch Ophthalmol 1962; 68:502.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanda T, Shibata M, Taguchi M, et al. Prevalence and aetiology of ocular hypertension in acute and chronic uveitis. Br J Ophthalmol 2014; 98:932.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Juanola X, Loza Santamaría E, Cordero-Coma M, SENTINEL Working Group. Description and Prevalence of Spondyloarthritis in Patients with Anterior Uveitis: The SENTINEL Interdisciplinary Collaborative Project. Ophthalmology 2016; 123:1632.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jabs DA, Busingye J. Approach to the diagnosis of the uveitides. Am J Ophthalmol 2013; 156:228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lou SM, Larkin KL, Winthrop K, et al. Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists. Ocul Immunol Inflamm 2015; 23:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Han YS, Rivera-Grana E, Salek S, Rosenbaum JT. Distinguishing Uveitis Secondary to Sarcoidosis From Idiopathic Disease: Cardiac Implications. JAMA Ophthalmol 2018; 136:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenbaum JT, Wernick R. The utility of routine screening of patients with uveitis for systemic lupus erythematosus or tuberculosis. A Bayesian analysis. Arch Ophthalmol 1990; 108:1291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hong BK, Khanamiri HN, Bababeygy SR, Rao NA. The utility of routine tuberculosis screening in county hospital patients with uveitis. Br J Ophthalmol 2014; 98:1091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ang M, Wong W, Ngan CC, Chee SP. Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis. Eye (Lond) 2012; 26:658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenbaum JT, Rahn DW. Prevalence of Lyme disease among patients with uveitis. Am J Ophthalmol 1991; 112:462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prieto JF, Dios E, Gutierrez JM, et al. Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm 2001; 9:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harper TW, Miller D, Schiffman JC, Davis JL. Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis. Am J Ophthalmol 2009; 147:140.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5581 Version 57.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16196117" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15596579" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : In vivo confocal microscopy of keratic precipitates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24825646" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Implications of the Pacific Ocular Inflammation uveitis epidemiology study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25835263" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Association between Smoking and Uveitis: Results from the Pacific Ocular Inflammation Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20036011" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Cigarette smoking as a risk factor for uveitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33609933" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Comprehensive pathogen detection for ocular infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33617392" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Epidemiology of Viral Induced Anterior Uveitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2184664" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Serologic tests in the diagnosis of presumed toxoplasmic retinochoroiditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11986090" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Ocular toxoplasmosis: clinical features and prognosis of 154 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1475754" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Ocular syphilis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10811077" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Prevalence of serologic evidence of cat scratch disease in patients with neuroretinitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9988158" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25950269" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Persistence of Ebola Virus in Ocular Fluid during Convalescence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26725449" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26865554" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Ocular Findings in Infants With Microcephaly Associated With Presumed Zika Virus Congenital Infection in Salvador, Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27332784" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Uveitis Associated with Zika Virus Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27939402" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Bilateral posterior uveitis associated with Zika virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34605447" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Retinal and choroidal manifestations of COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37611738" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Increased Incidence of Pediatric Uveitis Associated with the COVID-19 Pandemic Occurring Before COVID-19 Vaccine Implementation: A Time-Series Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34982290" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Ocular inflammatory events following COVID-19 vaccination: a multinational case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15234281" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1561400" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Acute anterior uveitis and spondyloarthropathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24928841" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19565479" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Enthesis inflammation in recurrent acute anterior uveitis without spondylarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2719509" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Uveitis. An internist's view.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3812615" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Changing patterns of uveitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1540555" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Uveitis and systemic disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/568886" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Sarcoidosis and its ophthalmic manifestations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3460394" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Ocular sarcoidosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3177566" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Course and outcome of ocular sarcoidosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/970993" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Eye inflammation in psoriatic arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9006426" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10627431" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Characterisation of uveitis in patients with psoriatic arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8341502" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25170065" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Characterisation of uveitis in association with multiple sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2025171" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24440284" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Diagnosis and classification of Vogt-Koyanagi-Harada disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23567866" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Vogt-Koyanagi-Harada syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1575232" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1970380" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5492449" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : The rate of visual loss in Behçet's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3661643" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Chronic anterior and posterior uveitis and primary Sjögren's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4647128" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Ocular findings in systemic lupus erythematosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3422014" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Lupus retinopathy. Patterns, associations, and prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22177107" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Patients with retinal vasculitis rarely suffer from systemic vasculitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9517787" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Uveitis and central nervous system vasculitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33848532" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Development of Classification Criteria for the Uveitides.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8284019" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10502577" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10624432" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28110950" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: Clinical Characteristics of 36 Eyes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30986442" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25275293" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Risk for uveitis with oral moxifloxacin: a comparative safety study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19851342" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/38110218" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Anterior uveitis and diffuse scleritis after pamidronate infusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32815757" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Immune Checkpoint Inhibitor-associated Uveitis: Review of Treatments and Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8510893" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Long-term visual outcome and complications associated with pars planitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15512983" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Multiple sclerosis-associated uveitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5920437" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : The incidence of uveitis in multiple sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2460128" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Birdshot chorioretinopathy: clinical characteristics and evolution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25211040" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Birdshot chorioretinopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1728143" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : HLA-A29.2 subtype associated with birdshot retinochoroidopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21958181" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Sympathetic ophthalmia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7383540" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of 105 cases (1913--1978).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25356928" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Nibbling away at the diagnosis of idiopathic uveitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11931783" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Chest computerized tomography in the evaluation of uveitis in elderly women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20691420" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Identification of new pathogens in the intraocular fluid of patients with uveitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32941857" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Revising the Diagnosis of Idiopathic Uveitis by Peripheral Blood Transcriptomics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13883604" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Epidemiology of uveitis. Incidence and prevalence in a small urban community.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24682184" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Prevalence and aetiology of ocular hypertension in acute and chronic uveitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27084561" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Description and Prevalence of Spondyloarthritis in Patients with Anterior Uveitis: The SENTINEL Interdisciplinary Collaborative Project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23668682" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Approach to the diagnosis of the uveitides.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25019973" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29327057" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Distinguishing Uveitis Secondary to Sarcoidosis From Idiopathic Disease: Cardiac Implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2205185" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : The utility of routine screening of patients with uveitis for systemic lupus erythematosus or tuberculosis. A Bayesian analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24489378" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : The utility of routine tuberculosis screening in county hospital patients with uveitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22302066" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1928255" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Prevalence of Lyme disease among patients with uveitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11449325" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Pars planitis: epidemiology, treatment, and association with multiple sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18834576" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
